The problem with these markers is the lack of sensitivity and specificity: only 20–30% of pure seminomas produce β-hCG and only every second non-seminoma TGCT has elevated LDH, AFP, or β-hCG levels [9]. The gene discussed is AFP; the disease is seminoma.